Healthcare Delivery to the rural area in Iran| Biomed Grid

The population explosion in Iran since 1979 uprising, mismanagement, and widespread corruption in the various echelon of Islamic government hierarchy has strained the neglected social infrastructure that has not kept up with the demands and changing demographics. This effect is apparent in the provision and delivery of primary healthcare to rural areas. The contributing factors, such as lack of health education to prepare sufficient numbers of health professionals and the distribution of medical services has not equitably reached all corners of the country. The significant gaps in accessing the medical care between different socioeconomic strata affected the rural healthcare delivery profoundly compared to urban settings. The healthcare system is part of the infrastructure, and its implementation is for the good of all Iranian and not as a business enterprise. Having said that there is a need to develop and implement a comprehensive universal/national healthcare policy; this can be achieved by considering the previous achievement and recognising the importance of solving future complex problems. This healthcare policy should cover the health education, delivery of healthcare and an efficient system free of corruption for reimbursement of healthcare professionals. It is essential to address these problems reasonably well to prevent the occurrence of them in the future secular government in Iran if ignored, that will prevent the recovery and revival of the nation at all levels. The new system should entail a non-profit government funded a system that is a universal, centralised/single-point healthcare insurance in Iran for all Iranian. The point to emphasise is that delivery of health; dental and pharmaceutical cares are not subject to entrepreneurship and profitmaking facilities. These are the fundamental needs of a society that is provided by a government. The funding for the healthcare is by collaboration with the universities educating the necessary health professional and financial support by pharmaceutical industries, private sectors and the government